<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.01">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.01" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-107066-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Programme de subventions de renforcement des capacit&#xE9;s en vue d&apos;essais en mati&#xE8;re de pr&#xE9;vention du VIH/sida : forum Synchronicity</narrative>
   <narrative xml:lang="EN">Synchronicity Forum - HIV/AIDS Prevention Trials Capacity-Building Program</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Si la pr&#xE9;vention du VIH/sida demeure une priorit&#xE9; mondiale, l&apos;Afrique est toujours la r&#xE9;gion la plus durement frapp&#xE9;e par l&apos;&#xE9;pid&#xE9;mie de sida. Gr&#xE2;ce au soutien financier de l&apos;Agence canadienne de d&#xE9;veloppement international (ACDI), l&apos;Initiative de recherche en sant&#xE9; mondiale (IRSM) g&#xE8;re la deuxi&#xE8;me phase du Programme de subventions de renforcement des capacit&#xE9;s en vue d&apos;essais en mati&#xE8;re de pr&#xE9;vention du VIH/sida (ICVV-II), qui vise le renforcement durable des comp&#xE9;tences en leadership et des capacit&#xE9;s des chercheurs et des &#xE9;tablissements africains en vue de leur permettre d&apos;effectuer ces essais &#xE0; l&apos;avenir. Pour ce faire, le programme soutient la collaboration et le r&#xE9;seautage entre les chercheurs africains et les utilisateurs de la recherche en Afrique en ce qui concerne ces essais. Le programme favorise en outre la collaboration et le r&#xE9;seautage entre les chercheurs et les &#xE9;tablissements canadiens et africains qui participent &#xE0; des essais &#xE0; l&apos;&#xE9;chelle mondiale. 

Afin de contribuer &#xE0; l&apos;atteinte de ces deux objectifs, le pr&#xE9;sent projet de soutien &#xE0; la recherche permettra &#xE0; l&apos;Institut de recherche de l&apos;H&#xF4;pital d&apos;Ottawa et &#xE0; la Kenya AIDS Vaccine Initiative d&apos;organiser un forum &#xE0; l&apos;intention des b&#xE9;n&#xE9;ficiaires de subventions dans le cadre du programme et d&apos;autres acteurs importants du Programme africain de vaccins contre le SIDA et du Partenariat des pays europ&#xE9;ens et en d&#xE9;veloppement sur les essais cliniques. Le forum comportera des s&#xE9;ances pl&#xE9;ni&#xE8;res, des communications, des discussions entre experts ainsi que des pr&#xE9;sentations par affiches. La grande incidence de cette r&#xE9;union sera la constitution d&apos;un solide r&#xE9;seau de b&#xE9;n&#xE9;ficiaires de subventions d&#xE9;termin&#xE9;s &#xE0; assurer une communication et &#xE0; une collaboration soutenues.</narrative>
   <narrative xml:lang="EN">While HIV/AIDS prevention remains a global health priority, Africa remains the region most affected by the AIDS epidemic.. The Global Health Research Initiative with funding from CIDA, manages the HIV/AIDS Prevention Trials Capacity Building Grants Program Phase II, which aims to create sustainable African capacity and leadership to conduct future HIV/AIDS prevention trials. It does so by supporting collaboration and networking of African researchers and research users in HIV/AIDS prevention trials. As well, it advances collaboration and networking among Canadian and African researchers and institutions in global HIV/AIDS prevention trial efforts. 

In advancing both of these objectives, this research support project  enables the Ottawa Hospital Research Institute and the Kenya AIDS Vaccine Initiative to organize a forum for research program grantees and other major players in the African AIDS Vaccine Partnership and the European and Developing Countries Clinical Trials Partnership. The forum will feature plenary presentations, oral abstract presentations, panel discussions, and a poster viewing session. The major outcome of this event will be a strong network of grant holders sharing a commitment to ongoing communication and collaboration.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
   <narrative xml:lang="EN">Canadian International Development Agency</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="60">
   <narrative xml:lang="FR">Institut de recherche de l&apos;H&#xF4;pital d&apos;Ottawa</narrative>
   <narrative xml:lang="EN">Ottawa Hospital Research Institute</narrative>
  </participating-org>
  <participating-org role="4" type="60">
   <narrative xml:lang="FR">Institut de recherche de l&apos;H&#xF4;pital d&apos;Ottawa</narrative>
   <narrative xml:lang="EN">Ottawa Hospital Research Institute</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2012-06-19" type="2"></activity-date>
  <activity-date iso-date="2013-10-19" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="KE" percentage="100"></recipient-country>
  <sector code="00003" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Children and Youth</narrative>
   <narrative xml:lang="FR">Enfants et jeunes</narrative>
  </sector>
  <sector code="13040" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="101" significance="1" vocabulary="99"></policy-marker>
  <policy-marker code="102" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="103" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="104" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2012-06-30"></transaction-date>
   <value currency="CAD" value-date="2012-06-30">197100</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherche de l&apos;H&#xF4;pital d&apos;Ottawa</narrative>
    <narrative xml:lang="EN">Ottawa Hospital Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2012-06-30"></transaction-date>
   <value currency="CAD" value-date="2012-06-30">100000</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherche de l&apos;H&#xF4;pital d&apos;Ottawa</narrative>
    <narrative xml:lang="EN">Ottawa Hospital Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2012-12-31"></transaction-date>
   <value currency="CAD" value-date="2012-12-31">83300</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherche de l&apos;H&#xF4;pital d&apos;Ottawa</narrative>
    <narrative xml:lang="EN">Ottawa Hospital Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-01-31"></transaction-date>
   <value currency="CAD" value-date="2014-01-31">13800</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherche de l&apos;H&#xF4;pital d&apos;Ottawa</narrative>
    <narrative xml:lang="EN">Ottawa Hospital Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on submission of a simplified accounting for the activity of funds received from IDRC.</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de pr&#xE9;senter une justification simplifi&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI.</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
